184 related articles for article (PubMed ID: 26462146)
21. Human telomeric G-quadruplex: the current status of telomeric G-quadruplexes as therapeutic targets in human cancer.
Neidle S
FEBS J; 2010 Mar; 277(5):1118-25. PubMed ID: 19951354
[TBL] [Abstract][Full Text] [Related]
22. Autophagy acts as a safeguard mechanism against G-quadruplex ligand-mediated DNA damage.
Orlotti NI; Cimino-Reale G; Borghini E; Pennati M; Sissi C; Perrone F; Palumbo M; Daidone MG; Folini M; Zaffaroni N
Autophagy; 2012 Aug; 8(8):1185-96. PubMed ID: 22627293
[TBL] [Abstract][Full Text] [Related]
23. Senescence and telomere shortening induced by novel potent G-quadruplex interactive agents, quindoline derivatives, in human cancer cell lines.
Zhou JM; Zhu XF; Lu YJ; Deng R; Huang ZS; Mei YP; Wang Y; Huang WL; Liu ZC; Gu LQ; Zeng YX
Oncogene; 2006 Jan; 25(4):503-11. PubMed ID: 16170347
[TBL] [Abstract][Full Text] [Related]
24. Aromatic core extension in the series of N-cyclic bay-substituted perylene G-quadruplex ligands: increased telomere damage, antitumor activity, and strong selectivity for neoplastic over healthy cells.
Franceschin M; Rizzo A; Casagrande V; Salvati E; Alvino A; Altieri A; Ciammaichella A; Iachettini S; Leonetti C; Ortaggi G; Porru M; Bianco A; Biroccio A
ChemMedChem; 2012 Dec; 7(12):2144-54. PubMed ID: 23097341
[TBL] [Abstract][Full Text] [Related]
25. Telomere-associated factor expression in replicative senescence of human embryonic lung fibroblasts.
Du H; Yang L; Xu XY; Hai L; Han YQ; Shi YX
Genet Mol Res; 2015 Aug; 14(3):9269-76. PubMed ID: 26345860
[TBL] [Abstract][Full Text] [Related]
26. Specifically targeting mixed-type dimeric G-quadruplexes using berberine dimers.
Li ZQ; Liao TC; Dong C; Yang JW; Chen XJ; Liu L; Luo Y; Liang YY; Chen WH; Zhou CQ
Org Biomol Chem; 2017 Dec; 15(48):10221-10229. PubMed ID: 29177319
[TBL] [Abstract][Full Text] [Related]
27. Oxidative damage in telomeric DNA disrupts recognition by TRF1 and TRF2.
Opresko PL; Fan J; Danzy S; Wilson DM; Bohr VA
Nucleic Acids Res; 2005; 33(4):1230-9. PubMed ID: 15731343
[TBL] [Abstract][Full Text] [Related]
28. Methods of studying telomere damage induced by quadruplex-ligand complexes.
Rizzo A; Salvati E; Biroccio A
Methods; 2012 May; 57(1):93-9. PubMed ID: 22410593
[TBL] [Abstract][Full Text] [Related]
29. G-Quadruplex binding enantiomers show chiral selective interactions with human telomere.
Wang J; Chen Y; Ren J; Zhao C; Qu X
Nucleic Acids Res; 2014 Apr; 42(6):3792-802. PubMed ID: 24413564
[TBL] [Abstract][Full Text] [Related]
30. Platinum(II) phenanthroimidazole G-quadruplex ligand induces selective telomere shortening in A549 cancer cells.
Mancini J; Rousseau P; Castor KJ; Sleiman HF; Autexier C
Biochimie; 2016 Feb; 121():287-97. PubMed ID: 26724375
[TBL] [Abstract][Full Text] [Related]
31. Up-regulating relaxin expression by G-quadruplex interactive ligand to achieve antifibrotic action.
Gu HP; Lin S; Xu M; Yu HY; Du XJ; Zhang YY; Yuan G; Gao W
Endocrinology; 2012 Aug; 153(8):3692-700. PubMed ID: 22673230
[TBL] [Abstract][Full Text] [Related]
32. G-quadruplexes: targets and tools in anticancer drug design.
Düchler M
J Drug Target; 2012 Jun; 20(5):389-400. PubMed ID: 22424091
[TBL] [Abstract][Full Text] [Related]
33. Looking for efficient G-quadruplex ligands: evidence for selective stabilizing properties and telomere damage by drug-like molecules.
Pagano B; Amato J; Iaccarino N; Cingolani C; Zizza P; Biroccio A; Novellino E; Randazzo A
ChemMedChem; 2015 Apr; 10(4):640-9. PubMed ID: 25694275
[TBL] [Abstract][Full Text] [Related]
34. New quinazoline derivatives for telomeric G-quadruplex DNA: effects of an added phenyl group on quadruplex binding ability.
He JH; Liu HY; Li Z; Tan JH; Ou TM; Huang SL; An LK; Li D; Gu LQ; Huang ZS
Eur J Med Chem; 2013 May; 63():1-13. PubMed ID: 23454529
[TBL] [Abstract][Full Text] [Related]
35. Triethylene tetramine, a novel ligand of G-quadruplex, induces senescence of MCF-7 cells.
Lixia G; Fei Y; Jiajia J; Jianhui L
Biotechnol Lett; 2008 Jan; 30(1):47-53. PubMed ID: 17846709
[TBL] [Abstract][Full Text] [Related]
36. Tetraplex structure of fission yeast telomeric DNA and its unfolding by the interaction with telomeric DNA binding protein Pot1.
Furukawa A; Torigoe H
Nucleic Acids Symp Ser (Oxf); 2005; (49):63-4. PubMed ID: 17150634
[TBL] [Abstract][Full Text] [Related]
37. The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function.
Burger AM; Dai F; Schultes CM; Reszka AP; Moore MJ; Double JA; Neidle S
Cancer Res; 2005 Feb; 65(4):1489-96. PubMed ID: 15735037
[TBL] [Abstract][Full Text] [Related]
38. Platinum(II) phenanthroimidazoles for targeting telomeric G-quadruplexes.
Castor KJ; Mancini J; Fakhoury J; Weill N; Kieltyka R; Englebienne P; Avakyan N; Mittermaier A; Autexier C; Moitessier N; Sleiman HF
ChemMedChem; 2012 Jan; 7(1):85-94. PubMed ID: 22052801
[TBL] [Abstract][Full Text] [Related]
39. A molecular model for drug binding to tandem repeats of telomeric G-quadruplexes.
Haider SM; Neidle S
Biochem Soc Trans; 2009 Jun; 37(Pt 3):583-8. PubMed ID: 19442254
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of cell proliferation by quindoline derivative (SYUIQ-05) through its preferential interaction with c-myc promoter G-quadruplex.
Ou TM; Lin J; Lu YJ; Hou JQ; Tan JH; Chen SH; Li Z; Li YP; Li D; Gu LQ; Huang ZS
J Med Chem; 2011 Aug; 54(16):5671-9. PubMed ID: 21774525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
